On September 30th we could see one of the biggest wealth generation opportunities of the fall, even the year.
That's when a small company located a few miles from the National Institutes of Health releases results on its Phase III trials for a medicine that could be required for every American child in the next year...
And shares in this small $7 stock could surge 100% or more in short order... and even higher.
Today very well could be your last chance to get in on the ground floor before this small firm becomes a household name, millions of investors become wealthy, and the stock price explodes.
Why? Because while the firm has committed to releasing Phase III trial results no later than the 30th, they could decide to release them earlier. And if you're not already holding a position in this stock you could miss the entire run up.
Click here to review my new briefing and get ahead of the crowd.
 Bret Jensen
Editor
Biotech Gems
P.S. On June 30th I shared with readers a similar opportunity with another small previously unknown drugmaker. In just over two months the share price is up 52%. This vaccine maker looks very likely to follow the same path to profits. Click here. | | |
If you enjoyed reading this email, click here to forward it to a friend or colleague.
You are receiving this message because you registered ignoble.experiment@arconati.us through INO.com Invite Sell - Apr 2014.
Click here to send us comments or questions regarding this mailing. Unsubscribe/update profile using link below.
This message from Investors Alley Corp. is being sent in full accordance with the CAN-SPAM Act.
We respect your privacy and, therefore, this email was sent directly from Investors Alley. Please review our Privacy Statement and Terms of Use.
If you no longer wish to receive emails from Investors Alley, please opt-out using the link below.
The opinions in this email and corresponding web sites are neither an offer nor a recommendation to buy or sell any security. Investors Alley Corp. and its affiliates may hold a position in any of the companies mentioned. Investors Alley Corp. is not a registered investment firm nor a broker/dealer. We urge you to always conduct your own research and due diligence and obtain professional advice before making any investment decision.
All information contained herein is copyright 2016, Investors Alley Corp.
Investors Alley Corporation | 41 Madison Avenue | 31st Floor | New York, NY 10010
Update Your Profile Information | Modify Subscription Settings or Unsubscribe From Emails
No comments:
Post a Comment
Keep a civil tongue.